Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Pai, Sara
Item TypeName
Academic Article Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects.
Concept Vaccines, DNA
Academic Article Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
Academic Article Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.
Academic Article Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.
Academic Article Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.
Academic Article A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response.
Academic Article Characterization of human papillomavirus type 11-specific immune responses in a preclinical model.
Academic Article Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
Academic Article Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes.
Academic Article Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.
Academic Article Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Academic Article Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.
Academic Article Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
Search Criteria
  • Vaccines DNA
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.